/Bristol-Myers%20Squibb%20Co_%20logo%20on%20building-by%20tatu%20Campelo%20via%20iStock.jpg)
Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) is one of the leading biopharmaceutical companies focused on developing treatments for diseases like cancer, inflammatory, immunologic, cardiovascular, and fibrotic diseases. With a market cap of $89.5 billion, Bristol-Myers’ operations span various countries in the Americas, Europe, and the Indo-Pacific.
The biopharma giant is set to unveil its third-quarter results before the market opens on Thursday, Oct. 30. Ahead of the event, analysts expect BMY to deliver a profit of $1.60 per share, down 11.1% from $1.80 per share reported in the year-ago quarter. On a positive note, the company has a solid earnings surprise history and has surpassed the Street’s bottom-line estimates in each of the past four quarters.